We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Del. Justices Uphold Fresenius' $4.3B Akorn Merger Drop

Law360 (December 7, 2018, 11:49 AM EST) -- Delaware's Supreme Court on Friday upheld a milestone Chancery Court finding that Fresenius Kabi AG had a right to terminate a $4.3 billion deal for generic-drug developer Akorn Inc., ruling less...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.